News

World AMR Awareness Week 2023: Joining forces to combat Antimicrobial Resistance

21 Nov, 2023

As we observe World AMR Awareness Week (WAAW) 2023, the theme of “Preventing antimicrobial resistance together” serves as a stark reminder of the collective responsibility we all share in preserving the effectiveness of these…
Read More

Register for the NeoIPC webinar: “Role and potential of surveillance in preventing hospital-acquired infections among newborns”

17 Nov, 2023

Hospital-acquired infections pose a significant risk to the health and wellbeing of newborns, especially preterm babies. The NeoIPC Clinical Practice Network will be holding a webinar focusing on the role and potential of…
Read More

NeoIPC launches new surveillance toolkit to bolster infection prevention and control efforts in NICUs

09 Nov, 2023

The NeoIPC Consortium is proud to announce the launch of a new surveillance toolkit to help neonatal intensive care units (NICUs) track and prevent hospital-acquired infections (HAIs) in high-risk newborns,…
Read More

Penta’s Young Reporters project shortlisted for Pharma Marketing Excellence Awards 

27 Oct, 2023

There is a growing need to ensure that knowledge generated from clinical trials is shared widely and accurately. However, young people often find themselves left out of this crucial exchange…
Read More

PentaTr@ining Uganda 2023: Empowering healthcare professionals

27 Oct, 2023

In the heart of Munyonyo, Uganda, on October 13-14, over 140 healthcare professionals and researchers gathered for our course, PentaTr@ining Uganda 2023. The bespoke two-day programme was a rich fusion…
Read More

D3 (PENTA 21) hosts investigators’ meeting in Uganda 

24 Oct, 2023

The D3 (PENTA 21) investigators’ meeting took place in Uganda on 12 October 2023, bringing together partners from South Africa, Spain, Thailand, UK and Uganda to discuss progress, challenges and…
Read More

New Penta/EACS HIV treatment guidelines 2023 available

19 Oct, 2023

The Penta/EACS HIV treatment guidelines 2023 were launched on the 18th October 2023 at the EACS conference in Poland. Guidance on preferred and alternative first-line antiretroviral therapy (ART) have been updated…
Read More

What to expect at a PK study day

02 Oct, 2023

A new animated video aimed at study participants explains what happens during a pharmacokinetics (PK) study. The video, which is now available to watch online in Lugandan, Isizulu and English,…
Read More

D3 trial completes recruitment ahead of schedule!

14 Sep, 2023

The D3 trial is excited to announce that it has successfully completed recruitment in the trial at an exceptional speed. D3 is looking to see if a new tablet, a…
Read More

PediCAP trial completes recruitment, investigating more child-friendly treatment options for severe community-acquired pneumonia

01 Sep, 2023

The PediCAP team is pleased to report that the 1100 patients required for the main trial in this study have now been recruited. PediCAP is an innovative, EDCTP funded clinical…
Read More

Nominate now for the Penta Brighter Future Award: celebrating visionary healthcare heroes

28 Jul, 2023

Do you know someone making a significant difference in healthcare, particularly for women and children? The Penta Brighter Future Award is here to recognise and celebrate those unsung heroes who…
Read More

Penta leads new scientific collaboration to improve treatment and reduce mortality of neonatal sepsis in Africa

27 Jul, 2023

A new European-African collaboration to improve the way infections in newborns are treated is launching today. The project, called SNIP-AFRICA, aims to reduce mortality among neonates in hospital with sepsis…
Read More

Discovering Australia: a trip to the International Workshop on HIV Pediatrics 2023

27 Jul, 2023

A warm welcome to my blog, thank you for joining me for the conference adventures!!!  Flying to Brisbane, was a beautiful journey, it was my first time going out of…
Read More

Gilead partners with CHAI and Penta to improve treatment and adherence rates among children with HIV in low and middle income countries

17 Jul, 2023

FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) is pleased to announce two public-private partnerships. The first will accelerate the development of an investigational dispersible pediatric formulation containing emtricitabine and…
Read More

Large-scale cohort research project invites researchers to participate in science challenge

17 Jul, 2023

ORCHESTRA opens doors to COVID-19 related data to selected scientists Verona 17/07/2023 – ORCHESTRA-Cohort is a multinational cohort research project on COVID-19 and its long-term sequelae. The collaborative data collection of…
Read More

Penta hosts workshops on long-acting injectable antiretrovirals for children and adolescents  

05 Jul, 2023

Between the months of April and May 2023, Penta hosted advisory group meetings where young people between the ages of 15 and 19 from South Africa, Argentina, the United Kingdom…
Read More

SMILE once-daily regimen non-inferior to triple ART regimen

28 Jun, 2023

Findings from the Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (PENTA-17) trial, simply known as SMILE, were published in eClinicalMedicine on 2 June 2023.…
Read More

Inaugural training session for UNIVERSAL’s Clinical Trial Management course

20 Jun, 2023

The inaugural Clinical Trial Management training program took place online on Wednesday, 14 June 2023, after 428 participants registered. The session was well attended by up to 168 clinical trial…
Read More
1 2 3 24